Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism

被引:882
作者
Christensen, Jakob [1 ,2 ]
Gronborg, Therese Koops [3 ]
Sorensen, Merete Juul [8 ]
Schendel, Diana [9 ]
Parner, Erik Thorlund [3 ]
Pedersen, Lars Henning [4 ,5 ]
Vestergaard, Mogens [6 ,7 ]
机构
[1] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark
[3] Aarhus Univ, Inst Publ Hlth, Dept Biostat, Aarhus, Denmark
[4] Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark
[5] Aarhus Univ, Inst Clin Med, Dept Obstet & Gynaecol, Aarhus, Denmark
[6] Aarhus Univ, Inst Publ Hlth, Res Unit, Aarhus, Denmark
[7] Aarhus Univ, Inst Publ Hlth, Sect Gen Practice, Aarhus, Denmark
[8] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark
[9] Ctr Dis Control & Prevent, Atlanta, GA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 309卷 / 16期
基金
英国医学研究理事会; 欧洲研究理事会;
关键词
BEHAVIORAL ALTERATIONS; ANIMAL-MODEL; ACID; CHILDREN; PREGNANCY; REGISTRATION; WOMEN; BIRTH; AGE;
D O I
10.1001/jama.2013.2270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Valproate is used for the treatment of epilepsy and other neuropsychological disorders and may be the only treatment option for women of childbearing potential. However, prenatal exposure to valproate may increase the risk of autism. Objective To determine whether prenatal exposure to valproate is associated with an increased risk of autism in offspring. Design, Setting, and Participants Population-based study of all children born alive in Denmark from 1996 to 2006. National registers were used to identify children exposed to valproate during pregnancy and diagnosed with autism spectrum disorders (childhood autism [autistic disorder], Asperger syndrome, atypical autism, and other or unspecified pervasive developmental disorders). We analyzed the risks associated with all autism spectrum disorders as well as childhood autism. Data were analyzed by Cox regression adjusting for potential confounders (maternal age at conception, paternal age at conception, parental psychiatric history, gestational age, birth weight, sex, congenital malformations, and parity). Children were followed up from birth until the day of autism spectrum disorder diagnosis, death, emigration, or December 31, 2010, whichever came first. Main Outcomes and Measures Absolute risk (cumulative incidence) and the hazard ratio (HR) of autism spectrum disorder and childhood autism in children after exposure to valproate in pregnancy. Results Of 655 615 children born from 1996 through 2006, 5437 were identified with autism spectrum disorder, including 2067 with childhood autism. The mean age of the children at end of follow-up was 8.84 years (range, 4-14; median, 8.85). The estimated absolute risk after 14 years of follow-up was 1.53% (95% CI, 1.47%-1.58%) for autism spectrum disorder and 0.48% (95% CI, 0.46%-0.51%) for childhood autism. Overall, the 508 children exposed to valproate had an absolute risk of 4.42% (95% CI, 2.59%-7.46%) for autism spectrum disorder (adjusted HR, 2.9 [95% CI, 1.7-4.9]) and an absolute risk of 2.50% (95% CI, 1.30%-4.81%) for childhood autism (adjusted HR, 5.2 [95% CI, 2.7-10.0]). When restricting the cohort to the 6584 children born to women with epilepsy, the absolute risk of autism spectrum disorder among 432 children exposed to valproate was 4.15% (95% CI, 2.20%-7.81%) (adjusted HR, 1.7 [95% CI, 0.9-3.2]), and the absolute risk of childhood autism was 2.95% (95% CI, 1.42%-6.11%) (adjusted HR, 2.9 [95% CI, 1.4-6.0]) vs 2.44% (95% CI, 1.88%-3.16%) for autism spectrum disorder and 1.02% (95% CI, 0.70%-1.49%) for childhood autism among 6152 children not exposed to valproate. Conclusions and Relevance Maternal use of valproate during pregnancy was associated with a significantly increased risk of autism spectrum disorder and childhood autism in the offspring, even after adjusting for maternal epilepsy. For women of childbearing potential who use antiepileptic medications, these findings must be balanced against the treatment benefits for women who require valproate for epilepsy control. JAMA. 2013;309(16):1696-1703 www.jama.com
引用
收藏
页码:1696 / 1703
页数:8
相关论文
共 36 条
[1]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[2]  
Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1
[3]   Antiepileptic drugs and apoptotic neurodegeneration in the developing brain [J].
Bittigau, P ;
Sifringer, M ;
Genz, K ;
Reith, E ;
Pospischil, D ;
Govindarajalu, S ;
Dzietko, M ;
Pesditschek, S ;
Mai, I ;
Dikranian, K ;
Olney, JW ;
Ikonomidou, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :15089-15094
[4]   AUTISM SPECTRUM DISORDERS FOLLOWING IN UTERO EXPOSURE TO ANTIEPILEPTIC DRUGS [J].
Bromley, R. L. ;
Mawer, G. ;
Clayton-Smith, J. ;
Baker, G. A. .
NEUROLOGY, 2008, 71 (23) :1923-1924
[5]   The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs [J].
Bromley, Rebecca Louise ;
Mawer, George E. ;
Briggs, Maria ;
Cheyne, Christopher ;
Clayton-Smith, Jill ;
Garica-Finana, Marta ;
Kneen, Rachel ;
Lucas, Sam B. ;
Shallcross, Rebekah ;
Baker, Gus A. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (06) :637-643
[6]   Validation of epilepsy diagnoses in the Danish National Hospital Register [J].
Christensen, Jakob ;
Vestergaard, Mogens ;
Olsen, Jorn ;
Sidenius, Per .
EPILEPSY RESEARCH, 2007, 75 (2-3) :162-170
[7]   Perinatal and Neonatal Risk Factors for Autism: A Comprehensive Meta-analysis [J].
Gardener, Hannah ;
Spiegelman, Donna ;
Buka, Stephen L. .
PEDIATRICS, 2011, 128 (02) :344-355
[8]   Postnatal concerns in children born to women with epilepsy [J].
Holmes, Gregory L. ;
Harden, Cynthia ;
Liporace, Joyce ;
Gordon, Jacki .
EPILEPSY & BEHAVIOR, 2007, 11 (03) :270-276
[9]   Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations. [J].
Jentink, Janneke ;
Loane, Maria A. ;
Dolk, Helen ;
Barisic, Ingeborg ;
Garne, Ester ;
Morris, Joan K. ;
de Jong-van den Berg, Lolkje T. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (23) :2185-2193
[10]   Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007 [J].
Kogan, Michael D. ;
Blumberg, Stephen J. ;
Schieve, Laura A. ;
Boyle, Coleen A. ;
Perrin, James M. ;
Ghandour, Reem M. ;
Singh, Gopal K. ;
Strickland, Bonnie B. ;
Trevathan, Edwin ;
van Dyck, Peter C. .
PEDIATRICS, 2009, 124 (05) :1395-1403